Voyager Therapeutics Inc/ US92915B1061 /
10/06/2024 22:00:00 | Diferencia +0.3500 | Volumen | Bid0:15:35 | Ask0:15:35 | Máximo del día | Price Change Band |
---|---|---|---|---|---|---|
8.7700USD | +4.16% | 461,877 Volumen de negocios: 2.86 millones |
8.2000Volumen de oferta: 100 | 8.6000Tamaño/ Volumen/ Formato de Ask: 6,900 | 8.7800 | 8.2000 |
GlobeNewswire
8:15
ROHM’s New TRCDRIVE pack™ with 2-in-1 SiC Molded Module: Significantly Reduces the Size of Electric ...
GlobeNewswire
8:00
FTI Consulting Appoints Senior Forensic Expert Dr. Stefan Heissner to the Forensic and Litigation Co...
GlobeNewswire
8:00
Bedford Metals Engages CanExplor Management for Satellite Survey of Ubiquity Lake Uranium Project
GlobeNewswire
8:00
Viridien Joins Forces with Ranch Computing to Supercharge the Digital Media Landscape
GlobeNewswire
7:45
GRITSTONE BIO, INC. (NASDAQ: GRTS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securitie...
GlobeNewswire
7:00
Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy
GlobeNewswire
7:00
Feutune Light Acquisition Corporation Announces that It Will Adjourn the Special Meeting of Stockhol...
GlobeNewswire
7:00
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPi...
GlobeNewswire
7:00
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
GlobeNewswire
6:00
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página